trial
as of 2026-07-01HOPE TEAM - Clinical High Risk Group CBSST
NCTId NCT03738046
at a glance
— · Withdrawn
Enrollment 0 (actual)
Sponsored by University of Pittsburgh Medical Center
Primary completion 2019-12-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2019-09-01
Primary completion
2019-12-01
Eligibility
ALL · 13 Years · 19 Years
Interventions & indications
Sponsors
University of Pittsburgh Medical CenterLead Sponsor
Investigators
1
Leslie Horton, PhDPrincipal Investigator
Sites
1 total
Pittsburgh, United States
Facts & assertions
4 sourced
Enrollment
0
Phase
NA
Primary Completion Date
2019-12-01
Status
WITHDRAWN
relationships
The graph out of here
drug
lead_sponsor
indication
investigator
person